Half-year report · HY
4892.TEDINET S100YWXA
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥104m | 2026-01-01 → 2026-06-30 | Standalone | Net sales |
| Revenue | ¥231m | 2025-01-01 → 2025-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥29m | 2025-01-01 → 2025-06-30 | Standalone | Net sales |
| Operating income | −¥418m | 2026-01-01 → 2026-06-30 | Standalone | Operating income |
| Operating income | −¥471m | 2025-01-01 → 2025-06-30 | Standalone | Operating income |
| Ordinary income | −¥433m | 2026-01-01 → 2026-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥761m | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥401m | 2025-01-01 → 2025-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥433m | 2026-01-01 → 2026-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥401m | 2025-01-01 → 2025-06-30 | Standalone | Income before income taxes |
| Net income | −¥435m | 2026-01-01 → 2026-06-30 | Standalone | Profit loss |
| Net income | −¥764m | 2025-01-01 → 2025-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥403m | 2025-01-01 → 2025-06-30 | Standalone | Profit loss |
| Total assets | ¥3.9bn | at 2026-06-30 | Standalone | Assets |
| Total assets | ¥4.3bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥3.2bn | at 2025-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.3bn | at 2026-06-30 | Standalone | Liabilities |
| Total liabilities | ¥1.5bn | at 2025-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.6bn | at 2026-06-30 | Standalone | Net assets |
| Net assets / equity | ¥2.8bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥2.3bn | at 2025-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.4bn | at 2026-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.8bn | at 2026-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2025-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2025-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥443m | 2026-01-01 → 2026-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥535m | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥284m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥201m | 2026-01-01 → 2026-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥398m | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥44m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥109m | 2026-01-01 → 2026-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.3bn | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥25m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-43.46 | 2026-01-01 → 2026-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-86.78 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-48.86 | 2025-01-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 63.6% | at 2026-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.3% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.4% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 10,092,100 | at 2026-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,611,800 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,373,600 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 423
| Item | Context | Value | Unit |
|---|---|---|---|
| Net increase decrease in cash and cash equivalents | InterimDuration_NonConsolidatedMember | -535007000 | JPY |
| Cash and cash equivalents | Prior2YearInstant_NonConsolidatedMember | 2052570000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 2376535000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant_NonConsolidatedMember | 1698671000 | JPY |
| Cash and cash equivalents | InterimInstant_NonConsolidatedMember | 1841527000 | JPY |
| Directors compensations sga | Prior1InterimDuration_NonConsolidatedMember | 52465000 | JPY |
| Directors compensations sga | InterimDuration_NonConsolidatedMember | 54915000 | JPY |
| Salaries allowances and bonuses sga | Prior1InterimDuration_NonConsolidatedMember | 27065000 | JPY |
| Salaries allowances and bonuses sga | InterimDuration_NonConsolidatedMember | 30417000 | JPY |
| Share based compensation expense major components of selling general and administrative expenses | Prior1InterimDuration_NonConsolidatedMember | 44470000 | JPY |
| Share based compensation expense major components of selling general and administrative expenses | InterimDuration_NonConsolidatedMember | 49397000 | JPY |
| Rent expenses on land and buildings | Prior1InterimDuration_NonConsolidatedMember | 12979000 | JPY |
| Rent expenses on land and buildings | InterimDuration_NonConsolidatedMember | 13013000 | JPY |
| Research and development expenses sga | Prior1InterimDuration_NonConsolidatedMember | 232506000 | JPY |
| Research and development expenses sga | InterimDuration_NonConsolidatedMember | 211992000 | JPY |
| Outsourcing expenses | Prior1InterimDuration_NonConsolidatedMember | 29339000 | JPY |
| Outsourcing expenses | InterimDuration_NonConsolidatedMember | 28786000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-08-14 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第17期中(自 2026年１月１日 至 2026年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社サイフューズ | |
| Company name in english cover page | FilingDateInstant | Cyfuse Biomedical K.K. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 秋枝 静香 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区三田三丁目５番27号 住友不動産東京三田サウスタワー | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-6435-1885（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 ＣＦＯ 経営管理部長 三條 真弘 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区三田三丁目５番27号 住友不動産東京三田サウスタワー | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-6435-1885（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 ＣＦＯ 経営管理部長 三條 真弘 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E38156 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 48920 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社サイフューズ | |
| Filer name in english | FilingDateInstant | Cyfuse Biomedical K.K. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2026-01-01 | |
| Current period end date | FilingDateInstant | 2026-06-30 | |
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2025-01-01 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |